Business Description
TOT Biopharm International Co Ltd
ISIN : HK0000545266
Compare
Compare
Traded in other countries / regions
01875.Hong Kong IPO Date
2019-11-08Description
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.02 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | -10.61 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.16 | |||||
Beneish M-Score | -1.94 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 192.6 | |||||
3-Year EPS without NRI Growth Rate | 59.9 | |||||
3-Year FCF Growth Rate | 28 | |||||
3-Year Book Growth Rate | -3.4 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.95 | |||||
9-Day RSI | 34.14 | |||||
14-Day RSI | 40.58 | |||||
6-1 Month Momentum % | 7.37 | |||||
12-1 Month Momentum % | -2.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.81 | |||||
Quick Ratio | 1.48 | |||||
Cash Ratio | 0.92 | |||||
Days Inventory | 195.7 | |||||
Days Sales Outstanding | 32.18 | |||||
Days Payable | 61.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.5 | |||||
Shareholder Yield % | -4.35 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.53 | |||||
Operating Margin % | -2.75 | |||||
Net Margin % | -4.84 | |||||
FCF Margin % | -18.8 | |||||
ROE % | -5.33 | |||||
ROA % | -2.78 | |||||
ROIC % | -2.41 | |||||
ROC (Joel Greenblatt) % | -5.06 | |||||
ROCE % | -3.15 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.63 | |||||
PB Ratio | 1.84 | |||||
Price-to-Tangible-Book | 1.91 | |||||
Price-to-Operating-Cash-Flow | 22.47 | |||||
EV-to-EBIT | -39.91 | |||||
EV-to-EBITDA | -39.91 | |||||
EV-to-Revenue | 1.67 | |||||
EV-to-FCF | -8.86 | |||||
Earnings Yield (Greenblatt) % | -2.51 | |||||
FCF Yield % | -11.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TOT Biopharm International Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 853.836 | ||
EPS (TTM) (HK$) | -0.055 | ||
Beta | 0.05 | ||
Volatility % | 34.08 | ||
14-Day RSI | 40.58 | ||
14-Day ATR (HK$) | 0.101027 | ||
20-Day SMA (HK$) | 2.285 | ||
12-1 Month Momentum % | -2.86 | ||
52-Week Range (HK$) | 0.8 - 3.4 | ||
Shares Outstanding (Mil) | 725.2 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TOT Biopharm International Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TOT Biopharm International Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
TOT Biopharm International Co Ltd Frequently Asked Questions
What is TOT Biopharm International Co Ltd(HKSE:01875)'s stock price today?
The current price of HKSE:01875 is HK$1.91. The 52 week high of HKSE:01875 is HK$3.40 and 52 week low is HK$0.80.
When is next earnings date of TOT Biopharm International Co Ltd(HKSE:01875)?
The next earnings date of TOT Biopharm International Co Ltd(HKSE:01875) is 2024-09-20 Est..
Does TOT Biopharm International Co Ltd(HKSE:01875) pay dividends? If so, how much?
TOT Biopharm International Co Ltd(HKSE:01875) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |